Cargando…
Population-based study of hormone receptor status comparing Oncotype DX with standard immunohistochemistry
Autores principales: | Baehner, FL, Maddala, T, Alexander, C, Gown, AM, Goldstein, LC, Achacoso, NS, Shak, S, Quesenberry, CP, Habel, LA |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284890/ http://dx.doi.org/10.1186/bcr2287 |
Ejemplares similares
-
HER2 assessment using fluorescence in situ hybridization compared with Oncotype DX and association with risk of breast cancer death
por: Baehner, FL, et al.
Publicado: (2009) -
The analytical validation of the Oncotype DX Recurrence Score assay
por: Baehner, Frederick L
Publicado: (2016) -
Correlation of Oncotype DX Recurrence Score with Histomorphology and Immunohistochemistry in over 500 Patients
por: Hanna, Matthew G., et al.
Publicado: (2017) -
Low utility of Oncotype DX® in the clinic
por: Ricks‐Santi, Luisel J., et al.
Publicado: (2017) -
Oncotype DX: Where Does It Stand in India?
por: Batra, Atul, et al.
Publicado: (2019)